SUPERCOMNET TECHNOLOGIES BHD

KLSE (MYR): SCOMNET (0001)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.28

Today's Change

+0.01 (0.79%)

Day's Change

1.25 - 1.29

Trading Volume

130,500

Financial

Show?
Last 10 FY Result
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 148,850 141,782 138,055 158,328 145,441 128,411 122,969 88,288 34,447 30,413 34,941 33,528 17.01%
PBT 41,662 40,298 37,901 42,867 32,378 30,453 23,613 16,092 2,033 2,332 2,972 720 55.28%
Tax -8,744 -8,432 -8,174 -9,864 -7,088 -7,867 -4,792 -3,919 556 14 11 57 -
NP 32,918 31,866 29,727 33,003 25,290 22,586 18,821 12,173 2,589 2,346 2,983 777 49.88%
-
NP to SH 32,918 31,866 29,727 33,003 25,290 22,586 18,821 12,173 2,589 2,346 2,983 777 49.88%
-
Tax Rate 20.99% 20.92% 21.57% 23.01% 21.89% 25.83% 20.29% 24.35% -27.35% -0.60% -0.37% -7.92% -
Total Cost 115,932 109,916 108,328 125,325 120,151 105,825 104,148 76,115 31,858 28,067 31,958 32,751 14.20%
-
Net Worth 426,284 426,284 364,827 327,510 311,366 240,822 205,759 135,255 43,740 41,310 41,310 38,799 28.25%
Dividend
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 25,075 16,097 15,524 15,233 11,391 10,155 9,645 - - 972 - - -
Div Payout % 76.18% 50.52% 52.22% 46.16% 45.04% 44.96% 51.25% - - 41.43% - - -
Equity
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 426,284 426,284 364,827 327,510 311,366 240,822 205,759 135,255 43,740 41,310 41,310 38,799 28.25%
NOSH 857,328 857,328 790,127 761,975 759,431 677,038 643,000 644,074 243,000 243,000 243,000 242,500 14.01%
Ratio Analysis
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 22.11% 22.48% 21.53% 20.84% 17.39% 17.59% 15.31% 13.79% 7.52% 7.71% 8.54% 2.32% -
ROE 7.72% 7.48% 8.15% 10.08% 8.12% 9.38% 9.15% 9.00% 5.92% 5.68% 7.22% 2.00% -
Per Share
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 17.81 16.96 17.79 20.79 19.15 18.97 19.12 13.71 14.18 12.52 14.38 13.83 2.83%
EPS 3.94 3.81 3.83 4.33 3.33 3.34 2.93 1.89 1.07 0.97 1.23 0.32 31.73%
DPS 3.00 1.93 2.00 2.00 1.50 1.50 1.50 0.00 0.00 0.40 0.00 0.00 -
NAPS 0.51 0.51 0.47 0.43 0.41 0.3557 0.32 0.21 0.18 0.17 0.17 0.16 12.71%
Adjusted Per Share Value based on latest NOSH - 857,328
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 17.30 16.47 16.04 18.40 16.90 14.92 14.29 10.26 4.00 3.53 4.06 3.90 17.00%
EPS 3.82 3.70 3.45 3.83 2.94 2.62 2.19 1.41 0.30 0.27 0.35 0.09 49.91%
DPS 2.91 1.87 1.80 1.77 1.32 1.18 1.12 0.00 0.00 0.11 0.00 0.00 -
NAPS 0.4953 0.4953 0.4239 0.3806 0.3618 0.2798 0.2391 0.1572 0.0508 0.048 0.048 0.0451 28.24%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 28/06/24 28/06/24 29/12/23 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 1.48 1.48 1.22 1.57 2.01 1.85 0.725 0.56 0.40 0.135 0.12 0.095 -
P/RPS 8.31 8.73 6.86 7.55 10.50 9.75 3.79 4.09 2.82 1.08 0.83 0.69 29.05%
P/EPS 37.58 38.82 31.86 36.23 60.36 55.46 24.77 29.63 37.54 13.98 9.78 29.65 0.80%
EY 2.66 2.58 3.14 2.76 1.66 1.80 4.04 3.38 2.66 7.15 10.23 3.37 -0.78%
DY 2.03 1.30 1.64 1.27 0.75 0.81 2.07 0.00 0.00 2.96 0.00 0.00 -
P/NAPS 2.90 2.90 2.60 3.65 4.90 5.20 2.27 2.67 2.22 0.79 0.71 0.59 17.90%
Price Multiplier on Announcement Date
AQR T4Q 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 27/08/24 27/08/24 28/02/24 21/02/23 22/02/22 12/03/21 27/02/20 01/03/19 28/02/18 28/02/17 29/02/16 27/02/15 -
Price 1.25 1.25 1.29 1.37 1.52 1.79 0.74 0.75 0.40 0.135 0.105 0.13 -
P/RPS 7.02 7.37 7.25 6.59 7.94 9.44 3.87 5.47 2.82 1.08 0.73 0.94 25.46%
P/EPS 31.74 32.79 33.68 31.62 45.64 53.66 25.28 39.68 37.54 13.98 8.55 40.57 -2.04%
EY 3.15 3.05 2.97 3.16 2.19 1.86 3.96 2.52 2.66 7.15 11.69 2.46 2.11%
DY 2.40 1.54 1.55 1.46 0.99 0.84 2.03 0.00 0.00 2.96 0.00 0.00 -
P/NAPS 2.45 2.45 2.74 3.19 3.71 5.03 2.31 3.57 2.22 0.79 0.62 0.81 14.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
7 people like this. Showing 50 of 4,414 comments

t_nike2002

Good prospect especially in medical and automotive sector.
Price is holding up and good upside moving forward

2024-01-12 11:43

INVEST_AA

Fruitcake with no substance statement

2024-01-15 15:44

Jerry87

Can you count on future projects when known products are already hopeless?

2024-01-16 10:07

Xcalibre

Automotive to Fully Recover by 2Q24
Management shared that 4Q23 automotive contribution would remain flat QoQ but full recovery is expected to happen by either 1Q24 or 2Q24. We understand that Scomnet’s customer, Stellantis is evaluating Gurun’s potential to be a regional hub for battery-electric vehicles (BEVs) for domestic and export markets. In essence, we believe the expansion of Stellantis in ASEAN (via Gurun, Kedah) will bode well for Scomnet.

In addition, Scomnet has been approached by a European automotive player to produce wire harness for Chrysler models in the US market. If successful, the first project is expected to begin in March or April 2024 and contribute around RM10-15mn sales per annum.

2024-01-17 14:40

Xcalibre

Medical Segment Sets to Grow Further
Moving into 4Q23, the group is confident that the medical segment contribution will increase by 15-20% QoQ driven by higher sales to Edward (40% of 3Q23 revenue) and recovery in orders from Ambu (29% of 3Q23 revenue). We note that Supercomnet has been chosen by Edwards Lifesciences (market cap of above USD50bn) as the best quality supplier (more than 700 suppliers) and achieved gold status in 2023. Edward will be using more digital smart cable (from analog cable) for its products such as its inbuilt PCB Board somewhere in the middle of 2024. For Ambu, the growth will come from endoscopes, gastroscopes and colonoscope (US FDA approved in Sep-23).

2024-01-17 14:40

Xcalibre

Full of potential..and lots of upsides

2024-01-17 14:40

Xcalibre

Investors are smart enough to know who’s the tin kosong (ie fruitcake) who just know how to make noise and post statements with NO substance…

2024-01-17 19:36

fruitcake

ok sorry. i delete all. good luck & all the best

2024-01-17 20:20

fruitcake

@xcalibre, is the price gone beyond sight?

2024-01-22 09:39

catalan

1 day down 3 cents, next day up 3 cents.

2024-01-24 17:33

TrendSculptor

wow, wat happened? Why the directors disposed the shares continuously?

2024-02-08 10:00

Michael Kwok

Buy call scomnet 1.30
Tp 1.80 range.
Is it real.will say yes.ini kali lah.
15/2/24 3.55pm

2024-02-15 15:55

Michael Kwok

Post removed.Why?

2024-02-15 15:58

TrendSculptor

Good Q4 result can be expected from Scomnet?

2024-02-20 15:46

NgWS90

Probably as Ambu's order has been recovering since the third quarter of last year

2024-02-26 15:51

fruitcake

loose cannons...taiwanese???

2024-03-01 12:32

NgWS90

Geopolitical risk is more likely ...

2024-03-04 15:13

Xcalibre

Price is rather high (PE 34x) while future upside is not that great..
Mermaid orders would be halted in April this year. Though it’s mentioned to be resumed by Sept when internal dispute is settled, there is uncertainty whether the dispute can be settled by then..

better wait for it the price to be cheaper first then only enter..

2024-03-06 10:07

NgWS90

What's the fair price of Scomnet to you, Xcalibre? 🙂🙂

2024-03-07 11:40

c328

Be cautious of this company.
Between August 2020 and March 2024,
they have continually added 170,117,400 shares through additional listings, which dilutes shareholder benefits. This trend of adding approximately 3,956,218 shares per month continues.

The management of this listed company is not sincere in fostering business growth;
instead, they manipulate share units for their own benefit.

2024-03-07 19:35

jackyjay

c328 ,
the Company issued FREE warrant of 1:3 to all existing shareholders on 2019, then they are eligible to convert warrant at RM0.65 per share (which the price are similar at the mother share price at 2019). So the convertion is a REWARD to shareholders who hold long term.

2024-03-08 08:14

NgWS90

I guess c328 missed out the bonus issue and became upset. ha

2024-03-08 18:26

c328

ha.. lets the market take time to digest all the dilution impact and production line impact first.

2024-03-08 23:36

NgWS90

Analysis of Scomnet from TA research. Quite good
https://www.thestar.com.my/business/business-news/2024/03/06/medical-segment-to-drive-supercomnet-earnings

2024-03-12 09:44

NgWS90

Directors bought back the shares. Got good news ?

2024-03-14 16:17

c328

boss always bought shares around +/- 1.20, boss knows how to earn money.

2024-03-18 11:56

NgWS90

Because boss also knows his own business very well 😁

2024-03-20 10:29

NgWS90

Scomnet is waking up and moving up

2024-04-03 17:31

NgWS90

EPF starts to collect Scomnet. It's a hint 😉

2024-04-18 07:30

NgWS90

Slide back down when it hits 1 year high price (Rm1.55) 😅

2024-04-25 15:50

NgWS90

Management sold too fast 😆

https://klse.i3investor.com/web/insider/detail/D_178307_150721058

2024-04-29 14:56

Nepo

omg today volume huge.
now only two distinct directions :-
1) Fly uppp and away
2) Crash and hard landing

You have to bet which direction it goes..

2024-04-29 16:04

c328

confirm up trend

2024-04-29 23:15

NgWS90

Nice, epf started tapping in 🤗
https://klse.i3investor.com/web/insider/detail/SBSH_584740_174085760

2024-05-06 10:17

c328

nope. it's normal, when have Exercise of Warrants - 2,224,166 shares at 0.650. Just wait.

2024-05-08 10:58

cherry88

Watch out for results announcement today or tomorrow. More excitment ahead

2024-05-20 15:57

NgWS90

Q1 result was out. Net profit improved QoQ and YoY due to increased in sales of medical products with better profit margin

2024-05-21 10:10

NgWS90

Sell at this price...? no way 😁 wait it move higher a bit 1st

2024-05-27 10:52

NgWS90

nice, EPF chipped in again

https://klse.i3investor.com/web/insider/detail/SBSH_586680_3225427302

2024-05-29 11:00

mf

Europe stocks extend losses after worst session for a month; Royal Mail owner IDS up 4% on sale agreement
Jenni Reid

2024-05-29 23:01

NgWS90

Scomnet is expected to rake in net profit of RM39.15 million this year, according to Bloomberg, compared to RM29.73 million in the previous year.

2024-06-04 17:26

NgWS90

Nice, EPF keeps on collecting. Breaking RM1.50 next week is possible 😊

2024-06-07 21:12

dchin472

scomnet gogogo

2024-06-12 09:58

NgWS90

Interesting, it went down instead after the agm ...

2024-06-13 17:33

NgWS90

Scomnet went back up after EPF collected continuously. ha

2024-07-01 17:09

NgWS90

Supercomnet looks for another shot in the arm in medical segment
https://theedgemalaysia.com/node/719123

2024-07-23 20:20

NgWS90

Commendable Q2 results but share price doesn't react ...
https://www.dagangnews.com/article/jualan-segmen-perubatan-supercomnet-pada-separuh-kedua-2024-diunjur-meningkat-kata-ta-securities-40338

2 months ago

NgWS90

Return to the slow upward trend this Scomnet 🤗

1 month ago

calvinfong_them

What happen to this stock??? keep dropping

1 month ago

NgWS90

Due to ESOS I think ...

1 month ago

Post a Comment